Pharmacological therapies for management of opium withdrawal

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Rahimi Movaghar, Afarin ^a   Hefazi, Mitra ^a   Davoli, Marina ^b   Amato, Laura ^b   Amin Esmaeili, Masoomeh ^a   Sahimi Izadian, Elahe ^a   Yousefi Nooraie, Reza ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ASL RM/E   (Italy)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUPRENORPHINE; METHADONE; OPIATE; OPIATE ANTAGONIST; PLACEBO;

CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; DISEASE DURATION; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG OVERDOSE; DRUG SAFETY; EMBASE; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; OPIATE ADDICTION; PATIENT SATISFACTION; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; PSYCINFO; RELAPSE; REVIEW; SOCIAL BEHAVIOR; SYSTEMATIC REVIEW; WITHDRAWAL SYNDROME;

EID: 70249098028     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007522     Document Type: Review

References (21)

1. Ahmadi J, Babaee-Beigi M, Alishahi M, Maany I, Hidari T. Twelvemonth maintenance treatment of opium-dependent patients. Jounal of Substance Abuse Treatment 2004;26(1):363-366 (Pubitemid 38041231)
2. Amato L, Davoli M, Ferri M, Ali R. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD003409]
3. Auriacombe M, Grabot D, Daulouede JP, Vergnolle JP, O'Brien C, Tignol J. A naturalistic follow-up study of French-speaking opiate-maintained heroin-addicted patients: effect on biopsychosocial status. Journal of Substance abuse Treatment 1994;11(6):565-568
4. Brunton LL, Lazo JS, Parker KL. In: Goodman, Gilman's editor(s). The pharmacological basis of therapeutics. 11th Edition. New York: Mc Graw Hill, 2006.
5. Gowing L, Farrell M, Ali R, White JM. Alpha2 adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD002024]
6. Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD002025]
7. Gowing L, Ali R, White JM. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD002022]
8. Gowing L, Ali R, White JM. Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD002021]
9. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. Available from www.cochrane-handbook.org. 2008.
10. Epidemiologic study of drug abuse in Iran. Tehran. IRANIAN MINISTRY OF HEALTH (IMoH) 2002.
11. Jittiwutikarn J, Ali R, White JM, Bochner F, Somogyi AA, Foster DJ. Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre. British Journal of Clinical Pharmacology 2004;58(5):536-541 (Pubitemid 39540458)
12. Kleber HD, Riordan CE. The treatment of narcotic withdrawal: a historical review. Journal of Clinical Psychiatry 1982;43(6 Pt 2):30-34
13. Methadone maintenance and harm reduction in northern Thailand. Presented by Chawalit Natpratan, Ministry of Public Health, Chiang Mai, Thailand 1996.
14. Thebaine. Public Chemical Database (PubChem) 2008.
15. Rahimi-Movaghar A, Izadian E, Yunesian M. Drug use situation in university students in Iran: a literature review. Payesh (Health Monitor) 2006;5:83-104.
16. Ray R. The Extent, Pattern and Trends of Drug Abuse in India-National Survey. Ministry of Social Justice and Empowerment, Government of India and United Nations Office on Drugs and Crime 2004.
17. Ray R, Kattimani S, Sharma H.K. Opium Abuse and Its Management: Global Scenario.World Health OrganizationDepartment of Mental Health and Substance AbuseManagement of Substance Abuse. National Drug Dependence Treatment Centre All IndiaInstitute of Medical Sciences New Delhi, India 2006.
18. Sweetman S. Martindale: The Complete Drug Reference. In: Sean C Sweetman BPharm FRPharmS editor(s). The Pharmaceutical Press.Book. London UK: Pharmaceutical Press, 2007. [: ISBN 0-85369-687-X]
19. UNODC. Afghanistan Drug Use Survey. Executive Summary and Fact Sheet. 2006.
20. WHO/EMRO. A Draft of the 5-Year REGIONAL STRATEGIC PLANNING ON SUBSTANCE ABUSE 2005-2009.. World Health OrganizationDepartment of Mental Health and Substance Abuse Management of Substance Abuse; National Drug Dependence Treatment Centre All India Institute of Medical Sciences New Delhi, India. 2004.
21. Yamazoe Y, Numata H, Yanagita T. Thebaine metabolites in the urine of rhesus monkeys. Japanese journal of pharmacology 1981;31(3):433-442 (Pubitemid 11072688)